Ernexa Therapeutics (ERNAW) Non-cash Items (2012 - 2025)

Ernexa Therapeutics has reported Non-cash Items for 12 years, with the latest figure at $1.4 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items fell 39.13% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (down 39.13% YoY), and the FY2025 full-year result was $1.4 million, down 39.13% from the prior year.
• Non-cash Items for Q4 2025 stood at $1.4 million, down from $2.3 million in the prior quarter.
• The five-year high for Non-cash Items was $18.5 million in Q1 2022, with the low at $1.4 million in Q4 2025.
• Historically, Non-cash Items has averaged $9.1 million across 4 years, with a median of $8.3 million in 2021.
• Annual changes were most pronounced in 2021 — Non-cash Items surged 1771.47% — and 2025, when it sank 39.13%.
• Ernexa Therapeutics' Non-cash Items stood at $14.3 million in 2021, then gained by 29.62% to $18.5 million in 2022, then slumped by 87.57% to $2.3 million in 2024, then sank by 39.13% to $1.4 million in 2025.
• The last three Non-cash Items figures came in at $1.4 million (Q4 2025), $2.3 million (Q4 2024), and $18.5 million (Q1 2022), per Business Quant data.